A clinical research of endoscopic submucosal dissection for ileocecal valve lipoma
- VernacularTitle:内镜黏膜下剥离术治疗回盲瓣脂肪瘤的临床分析
- Author:
Shaobin LUO
1
;
Li WANG
1
;
Keyang FAN
1
;
Zuqiang LIU
1
;
Hao HU
1
;
Wenzheng QIN
1
;
Zhen ZHANG
1
;
Mingyan CAI
1
;
Jianwei HU
1
;
Lili MA
1
;
Yiqun ZHANG
1
;
Yunshi ZHONG
1
;
Quanlin LI
1
;
Pinghong ZHOU
1
Author Information
- Publication Type:Journal Article
- Keywords: Lipoma; Ileocecal valve; Endoscopic submucosal dissection
- From: Chinese Journal of Digestive Endoscopy 2025;42(6):469-473
- CountryChina
- Language:Chinese
- Abstract: Objective:To evaluate the efficacy and safety of endoscopic submucosal dissection (ESD) for the treatment of ileocecal valve lipoma.Methods:A retrospective cohort study was performed on data of ileocecal lipoma patients who underwent ESD at the Endoscopy Center of Zhongshan Hospital, Fudan University from December 2013 to June 2023. According to the lesion location, the patients were divided into ileocecal valve group and cecum group. The operation time, operation speed, en bloc resection rate, complications, and follow-up outcomes between the two groups were compared.Results:A total of 59 patients with ileocecal lipoma were enrolled, including 31 patients in the ileocecal valve group and 28 patients in the cecum group.There were no significant differences in gender, age, specimen size, or lesion size between the two groups ( P>0.05). Lipomas in both the ileocecal valve group and the cecum group were successfully resected by ESD. The en bloc resection rates were 100.0% (31/31) and 92.9% (26/28) respectively, and the difference was not statistically significant ( χ2=0.033, P=0.133). Median operative duration significantly differed between the two groups ( ileocecal valve group 26 min VS cecum group 20 min, Z=-0.136, P=0.027), as did resection speed (ileocecal valve group 0.14 cm2/min VS cecum group 0.24 cm2/min, Z=-0.223, P=0.022). Adverse events included one postoperative fever in the ileocecal valve group and one delayed bleeding in the cecum group. During the median follow-up of 38 months (7-106 months), there was no case of residual tumor or recurrence. Conclusion:Despite technical challenges in ESD of ileocecal valve lipoma, it is still a safe, feasible and effective treatment method.
